Solarvest Sells PEI Facility
Vancouver, British Columbia--(Newsfile Corp. - September 30, 2024) - Solarvest BioEnergy Inc. (TSXV: SVS.H) ("Solarvest", or the "Company"), an algal biologic company specializing in organic ingredient production and commercial marketing of pharmaceutical grade ingredients and health supplements, announces the pending sale of the Summerville Prince Edward Island manufacturing and R&D facility.The net proceeds from the sale of 3867 Greenfeild Rd, Summerville, PEI, expected in November 2024,...
2024-09-30 9:06 AM EDT
Solarvest Elects New Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - June 6, 2024) - Solarvest BioEnergy Inc. (TSXV: SVS.H) ("Solarvest", or the "Company"), an algal biologic company specializing in organic ingredient production and commercial marketing of pharmaceutical grade ingredients and health supplements, is pleased to announce the election of a new board of directors, voted and approved by shareholders, to lead the transition and focused restructuring of Solarvest.At the 2024 annual meeting of shareholders...
2024-06-06 10:00 PM EDT
Solarvest Announces Annual General Meeting of Shareholders
Vancouver, British Columbia--(Newsfile Corp. - April 3, 2024) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest" or the "Company") is pleased to announce that it intends to hold its annual general meeting of shareholders (the "Meeting") on May 10, 2024 in Vancouver, British Columbia. The specific time, location and format of the Meeting will be provided in the Company's notice of meeting and management information circular, which will be filed on the Company's SEDAR profile at...
2024-04-03 9:04 AM EDT
Solarvest Transition to NEX
Vancouver, British Columbia--(Newsfile Corp. - January 12, 2024) - Further to Solarvest's (TSXV: SVS.H) (or "the Company"s) press releases dated May 3, 2023 and July 24, 2023 and to the Exchange's Notice to transfer to NEX dated September 15, 2023, the Company confirms that the Exchange has issued a bulletin to transfer the Company's securities to NEX effective at the opening on Tuesday, January 9, 2024. Currently, trading remains suspended.The Company is pursuing the sale of the building...
2024-01-12 5:00 PM EST
Solarvest BioEnergy Announces Update on Notice of Requisition for General Meeting
Vancouver, British Columbia--(Newsfile Corp. - August 28, 2023) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest" or the "Company") announces that, further to its news release of August 3, 2023, a Notice of Requisition for General Meeting delivered by Garth Greenham and LMC Communications Inc. dated July 24, 2023 has been recognized as valid by the Company and accordingly has scheduled a meeting of shareholders (the "Meeting") for November 24, 2023 in accordance with the provisions of the...
2023-08-28 8:53 AM EDT
Solarvest Receipt of Notice of Requisition of a Meeting of Shareholders
Vancouver, British Columbia--(Newsfile Corp. - August 3, 2023) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest" or the "Company") announces, that a notice of requisition of a general meeting of shareholders (the "Requisition") was delivered to the registered office of the Company on July 24, 2023.The Requisition has been made by Garth Greenham and LMC Communications Inc. and would, if valid, require that the Company call and hold a general meeting of shareholders, pursuant to section 167...
2023-08-03 8:00 AM EDT
Solarvest Receives Approval for Its Unique Algal Juice Media Patent
Vancouver, British Columbia--(Newsfile Corp. - July 27, 2023) - The Company (TSXV: SVS) is very pleased to announce that it has received Notice of Allowance and Notice of Allowability from the U.S. Patent & Trademark Office for it US Algal Juice Media Patent Application, U.S. Patent Application No.: 14/896,809 - METHODS AND PRODUCING ALGAL CELL CULTURES AND BIOMASS, LIPID COMPOUNDS AND COMPOSITIONS, AND RELATED PRODUCTS - RIVEROLL et al.Solarvest CEO Claes Ellegaard comments, "We are very...
2023-07-27 4:22 PM EDT
TSX-V Grant Solarvest CLR Extension to August 31, 2023
Vancouver, British Columbia--(Newsfile Corp. - July 24, 2023) - Further to press release dated May 3, 2023, the TSX Venture Exchange ("TSX-V") requested Solarvest (TSXV: SVS) (or "the Company") to provide a detailed analysis, subject to review and acceptance, to meet Tier 2 Continued Listing Requirements ("CLR") by July 20, 2023.The Company is pleased to announce that it has been granted an extension to August 31, 2023 after submitting a detailed response for consideration to the TSX-V, to...
2023-07-24 5:00 PM EDT
Notice for NEX
Vancouver, British Columbia--(Newsfile Corp. - May 3, 2023) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest" or the "Company") wishes to provide an update regarding its corporate activities.Further to the update provided on April 19, 2023, the Company confirms that it is on notice to have its listing transferred to the NEX board of the TSX Venture Exchange. As such, the Company has until July 20, 2023 to provide its analysis how it intends to meet Tier 2 Continued Listing Requirements...
2023-05-03 5:00 PM EDT
Solarvest Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - April 19, 2023) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest" or the "Company") wishes to provide an update regarding its corporate activities.The Company has been in discussions with various financing sources, including existing shareholders, for additional working capital. Unfortunately, the response from these groups has been unsuccessful to date and, due to an immediate cash flow shortage, the Company has been forced to halt operations...
2023-04-19 7:27 PM EDT
Solarvest Reports Second Quarter Fiscal 2022 Financial Results
Vancouver, British Columbia--(Newsfile Corp. - March 31, 2023) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest" or the "Company") wishes to report that it has filed its interim financial results for the six-month period ended January 31, 2023. Solarvest's financial statements (the "Financial Statements") are prepared in accordance with International Financial Reporting Standards. Full copies of the Financial Statements, accompanying management discussion and analysis ("MD&A") and officer...
2023-03-31 5:00 PM EDT
Solarvest BioEnergy's New Fixed Stock Option Plan Accepted by TSXV; Option Grants to Directors, Officers and Consultants
Vancouver, British Columbia--(Newsfile Corp. - March 3, 2023) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest" or the "Company") is pleased to announce that, further to its news releases of September 22 and November 3, 2022, the TSX Venture Exchange (the "Exchange") has accepted for filing its new fixed stock option plan (the "2022 Plan"). The 2022 Plan reserves a total of 11,067,000 common shares for issuance pursuant to the grant of stock options. All outstanding options from the...
2023-03-03 6:01 PM EST
Solarvest BioEnergy's Non-Brokered Private Placement Receives Final Exchange Acceptance
Vancouver, British Columbia--(Newsfile Corp. - February 23, 2023) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest", or the "Company"), is pleased to announce that, further to its news release of February 9, 2023, it has received final acceptance from the TSX Venture Exchange ("Exchange") for its previously announced non-brokered private placement (the "Offering") which closed in two tranches on December 16, 2022 (the "First Tranche") and February 7, 2023 (the "Second Tranche") respectively...
2023-02-23 5:00 PM EST
Solarvest BioEnergy Inc. Announces Grant of Stock Options, Re-Pricing of Existing Stock Options and Adoption of New Fixed Stock Option Plan
Vancouver, British Columbia--(Newsfile Corp. - September 22, 2022) - Solarvest BioEnergy Inc. (TSXV: SVS) ("Solarvest" or the "Company") announces that pursuant to the Company's existing Stock Option Plan, a total of 1,000,000 incentive stock options have been granted to a consultant of the Company. These stock options are exercisable at a price of $0.12 per share for a period of 2 years expiring August 1, 2024.The Company also wishes to announce that it intends to re-price an aggregate of...
2022-09-22 2:51 PM EDT
Solarvest Files Quarterly Financial Statements and MD&A
Vancouver, British Columbia--(Newsfile Corp. - December 31, 2021) - Solarvest BioEnergy Inc. ("Solarvest" or the "Company") (TSXV: SVS) is pleased to announce that its quarterly statements for the period ended October 31, 2021, related management discussion and analysis have been filed and are now available on www.sedar.com.For the three months ended October 31, 2021 the Company incurred a net loss of $383,510 compared to a net loss of $1,565,335 for the prior year. At October 31, 2021, the...
2021-12-31 4:30 PM EST